c-Fgr Polyclonal Antibody

FGR is a member of the Src family of protein tyrosine kinases (PTKs). The encoded protein (FGR proto-oncogene, Src family tyrosine kinase) contains N-terminal sites for myristylation and palmitylation, a PTK domain, and SH2 and SH3 domains which are involved in mediating protein-protein interactions with phosphotyrosine-containing and proline-rich motifs, respectively. The protein localizes to plasma membrane ruffles, and functions as a negative regulator of cell migration and adhesion triggered by the beta-2 integrin signal transduction pathway. Infection with Epstein-Barr virus results in the overexpression of FGR. Multiple alternatively spliced variants, encoding the same protein, have been identified.

Introducing the C-FGR Polyclonal Antibody, a cutting-edge scientific tool designed to revolutionize research in the field of immunology. This meticulously crafted antibody is meticulously developed using state-of-the-art techniques, ensuring unparalleled specificity and sensitivity.

The C-FGR Polyclonal Antibody is meticulously purified to guarantee exceptional quality and reliability. Its unique composition enables it to target and bind to the C-FGR protein with utmost precision, facilitating accurate detection and analysis. This antibody's exceptional affinity and selectivity make it an invaluable asset for researchers seeking to explore the intricate mechanisms of immune response.

With its robust performance, the C-FGR Polyclonal Antibody offers a wide range of applications, including immunohistochemistry, western blotting, and flow cytometry. Its versatility allows for seamless integration into various experimental protocols, providing researchers with the flexibility needed to achieve groundbreaking results.

Furthermore, the C-FGR Polyclonal Antibody is rigorously validated to ensure consistent performance across different experimental conditions. Its exceptional stability and long shelf life guarantee reliable results, making it an indispensable tool for both basic and clinical research.

In summary, the C-FGR Polyclonal Antibody represents a breakthrough in immunological research, offering unparalleled specificity, sensitivity, and versatility. With its exceptional performance and reliability, this antibody is poised to revolutionize the field, empowering researchers to unravel the complexities of immune response and drive scientific advancements.